Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cirqle Biomedical Contraception Aps is currently engaged in the prosecution of 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct art unit, indicating that the company's current patenting activity is focused on a specific technical niche. The process involves 1 distinct examiner, which simplifies the management of the company's active applications. For a practitioner, this indicates that the legal strategy can be narrowly tailored to the specific examination standards of this technical division.
The busiest examiner for the portfolio is OLSON, ANDREA STEFFEL, who is responsible for 1 busiest examiner pending office action. Since the company only has 1 distinct examiner for its active matters, the success of its current prosecution efforts depends on the specific feedback from this examiner. The concentration in 1 distinct art unit reflects a targeted approach to securing intellectual property within the biotechnology sector. This centralized prosecution profile minimizes the complexity often found in larger portfolios that span multiple art units and examiners, allowing for a highly targeted patenting strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OLSON, ANDREA STEFFEL | 1 | 62.3% | -11.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18283757 | A VAGINAL CONTRACEPTIVE COMPOSITION FOR REINFORCEMENT OF THE CERVICAL MUCUS BARRIER PROPERTIES | OLSON, ANDREA STEFFEL | 23d overdue |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18283757 | A VAGINAL CONTRACEPTIVE COMPOSITION FOR REINFORCEMENT OF THE CERVICAL MUCUS BARRIER PROPERTIES | OLSON, ANDREA STEFFEL | 1693 | §102§103Other | Final Rejection | 23d overdue | Pending | Sep 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial